Request a Premium Quote Breaking News Guardant Health Begins SHIELD Trial for Lung Cancer Early Detection FDA Clears Kinnate Biopharma's IND for FGFR Inhibitor in Bile Duct, Urothelial Cancers Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Eisbach Bio, MD Anderson Partner to Identify Synthetic Lethal Drug Targets AstraZeneca, Daiichi Sankyo File for FDA Enhertu Approval in Second-Line HER2-Postive Breast Cancer Lantern Pharma Collaborating With Danish Cancer Research Center on Drugs for NER-Deficient Tumors
